Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe

V Thakur, S Bhola, P Thakur, SKS Patel, S Kulshrestha… - Infection, 2022 - Springer
The coronavirus disease-19 has left a permanent mark on the history of the human race.
Severe acute respiratory syndrome coronavirus-2 is a positive-sense single-stranded RNA …

Potential therapeutic options for COVID-19: an update on current evidence

Z Niknam, A Jafari, A Golchin, F Danesh Pouya… - European journal of …, 2022 - Springer
Abstract SARS-CoV-2, a novel coronavirus, is the agent responsible for the COVID-19
pandemic and is a major public health concern nowadays. The rapid and global spread of …

Emerging evidence on Omicron (B. 1.1. 529) SARS‐CoV‐2 variant

V Sharma, H Rai, DNS Gautam… - Journal of Medical …, 2022 - Wiley Online Library
COVID's Omicron variant has sparked a slew of concerns across the globe. This review aims
to provide a brief overview of what we know about the Omicron variant right now. The new …

[PDF][PDF] Impact of the novel coronavirus on stock market returns: evidence from GCC countries

R Bahrini, A Filfilan - Quantitative Finance and Economics, 2020 - aimspress.com
The novel coronavirus (COVID-19) is not only an unprecedented human and health crisis,
but it is expected to become one of the most economically costly pandemics in recent …

Drug repurposing strategy (DRS): Emerging approach to identify potential therapeutics for treatment of novel coronavirus infection

BM Sahoo, BVV Ravi Kumar, J Sruti… - Frontiers in Molecular …, 2021 - frontiersin.org
Drug repurposing is also termed as drug repositioning or therapeutic switching. This method
is applied to identify the novel therapeutic agents from the existing FDA approved clinically …

Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review

S Das, SS Kar, S Samanta, J Banerjee, B Giri… - Immunologic …, 2022 - Springer
SARS-CoV-2 is an RNA virus that was identified for the first time in December 2019 in
Wuhan, China. The World Health Organization (WHO) labeled the novel coronavirus …

Barriers to and strategies to address COVID-19 testing hesitancy: a rapid sco** review

M Embrett, SM Sim, HAT Caldwell, L Boulos, Z Yu… - BMC public health, 2022 - Springer
Background Testing is a foundational component of any COVID-19 management strategy;
however, emerging evidence suggests that barriers and hesitancy to COVID-19 testing may …

[HTML][HTML] Bench-to-bedside: Translational development landscape of biotechnology in healthcare

C Liao, S **ao, X Wang - Health Sciences Review, 2023 - Elsevier
Biotechnology is a rapidly evolving field that has the potential to transform the way we
diagnose and treat diseases and is changing the landscape of healthcare. Great endeavors …

[PDF][PDF] Analisis dampak Covid-19 terhadap kesadaran masyarakat dalam penerapan protokol kesehatan

AA Saputro, YD Saputra, GB Prasetyo - Jurnal Porkes, 2020 - scholar.archive.org
Virus Corona merupakan jenis virus baru yang kini tengah menggemparkan dunia karena
telah menginfeksi ribuan juta manusia di dunia dalam waktu yang singkat. Mengantisipasi …

Potential role of interferons in treating COVID-19 patients

MH Abdolvahab, S Moradi-Kalbolandi, M Zarei… - International …, 2021 - Elsevier
The recently public health crises in the world is emerged by spreading the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) also named COVID-19. The virus is …